Ian F Slack1, Justin T Schwartz1, Vincent A Mukkada2, Shawna Hottinger1, J Pablo Abonia3. 1. Division of Allergy and Immunology, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 7028, Cincinnati, OH, 45229, USA. 2. Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. 3. Division of Allergy and Immunology, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 7028, Cincinnati, OH, 45229, USA. Pablo.Abonia@cchmc.org.
Abstract
PURPOSE OF REVIEW: Recent research efforts have spurred great progress in the diagnosis and management of eosinophilic esophagitis (EoE). Nonetheless, challenges remain in addressing disease burden and impairment in the growing EoE population. We highlight work from the Cincinnati Center for Eosinophilic Disorders, the Consortium of Eosinophilic Gastrointestinal Disease Researchers, and others that address these ongoing challenges. RECENT FINDINGS: New tools for characterizing EoE disease activity include the EoE Histology Scoring System (EoEHSS), endoscopic alternatives, validated patient-reported outcome (PRO) questionnaires, and investigational biomarkers. These diagnostic and monitoring strategies have been complemented by advances in EoE therapy. Treatment modalities have refined the traditional approaches of dietary elimination, swallowed steroids, and proton pump inhibitors (PPI), and biologics offer promise for future treatment. This review summarizes EoE advances in disease management and newly defined EoE endotypes that may serve as the foundation for EoE-personalized medicine.
PURPOSE OF REVIEW: Recent research efforts have spurred great progress in the diagnosis and management of eosinophilic esophagitis (EoE). Nonetheless, challenges remain in addressing disease burden and impairment in the growing EoE population. We highlight work from the Cincinnati Center for Eosinophilic Disorders, the Consortium of Eosinophilic Gastrointestinal Disease Researchers, and others that address these ongoing challenges. RECENT FINDINGS: New tools for characterizing EoE disease activity include the EoE Histology Scoring System (EoEHSS), endoscopic alternatives, validated patient-reported outcome (PRO) questionnaires, and investigational biomarkers. These diagnostic and monitoring strategies have been complemented by advances in EoE therapy. Treatment modalities have refined the traditional approaches of dietary elimination, swallowed steroids, and proton pump inhibitors (PPI), and biologics offer promise for future treatment. This review summarizes EoE advances in disease management and newly defined EoE endotypes that may serve as the foundation for EoE-personalized medicine.
Authors: Ikuo Hirano; Margaret H Collins; Yehudith Assouline-Dayan; Larry Evans; Sandeep Gupta; Alain M Schoepfer; Alex Straumann; Ekaterina Safroneeva; Michael Grimm; Heather Smith; Cindy-Ann Tompkins; Amy Woo; Robert Peach; Paul Frohna; Sheila Gujrathi; Darryl N Penenberg; Caiyan Li; Gregory J Opiteck; Allan Olson; Richard Aranda; Marc E Rothenberg; Evan S Dellon Journal: Gastroenterology Date: 2018-11-02 Impact factor: 22.682
Authors: Li Zuo; Patricia C Fulkerson; Fred D Finkelman; Melissa Mingler; Christine A Fischetti; Carine Blanchard; Marc E Rothenberg Journal: J Immunol Date: 2010-06-11 Impact factor: 5.422
Authors: J Pablo Abonia; Ting Wen; Emily M Stucke; Tommie Grotjan; Molly S Griffith; Katherine A Kemme; Margaret H Collins; Philip E Putnam; James P Franciosi; Karl F von Tiehl; Brad T Tinkle; Keith A Marsolo; Lisa J Martin; Stephanie M Ware; Marc E Rothenberg Journal: J Allergy Clin Immunol Date: 2013-04-19 Impact factor: 10.793
Authors: Robert A Nathan; Christine A Sorkness; Mark Kosinski; Michael Schatz; James T Li; Philip Marcus; John J Murray; Trudy B Pendergraft Journal: J Allergy Clin Immunol Date: 2004-01 Impact factor: 10.793
Authors: James P Franciosi; Kevin A Hommel; Charles W DeBrosse; Allison B Greenberg; Alexandria J Greenler; J Pablo Abonia; Marc E Rothenberg; James W Varni Journal: BMC Gastroenterol Date: 2011-11-18 Impact factor: 3.067
Authors: Glenn T Furuta; Amir F Kagalwalla; James J Lee; Preeth Alumkal; Brian T Maybruck; Sophie Fillon; Joanne C Masterson; Sergei Ochkur; Cheryl Protheroe; Wendy Moore; Zhaoxing Pan; Katie Amsden; Zachary Robinson; Kelley Capocelli; Vince Mukkada; Dan Atkins; David Fleischer; Lindsay Hosford; Mark A Kwatia; Shauna Schroeder; Caleb Kelly; Mark Lovell; Hector Melin-Aldana; Steven J Ackerman Journal: Gut Date: 2012-08-15 Impact factor: 23.059
Authors: Anna Henderson; Adam Magier; Justin T Schwartz; Lisa J Martin; Margaret H Collins; Philip E Putnam; Vincent A Mukkada; J Pablo Abonia; Marc E Rothenberg; Patricia C Fulkerson Journal: J Pediatr Gastroenterol Nutr Date: 2020-04 Impact factor: 3.288